Below is information TMA sent out for upcoming live discussions. We will be sending out reminders of these live discussions as they get nearer – but mark your calendars now!
Note: TMA shares information via email blasts, and while we try to repost these for the group we don’t want to be too repetitive for members who already subscribe to TMA. If you want to be kept fully informed of what is happening with TMA we suggest you follow them on Facebook, click here, or signup as a TMA member (membership is free!), click here.
TMA schedules winter online discussions with medical experts.
There will be several online question and answer sessions with members of TMA’s Medical Advisory Board during the next few months. Listed below are the topics, MAB member answering questions, date and time for these online discussions.
For those of you unfamiliar with the discussions, here’s how they work:
A week or so beforehand you can submit your questions in advance. The MAB member will choose the questions to answer — usually those of most general interest — and you’ll see both the question and answer posted during the live discussion. You can also ask questions online after the discussion begins. We ask people who are participating in the live discussion to try avoiding asking questions that have already been answered so that we can answer as many unique questions as possible during the hour-long discussion.
Dr. Steven Greenberg: BYM338 – Novartis Breakthrough Therapy for IBM
Monday, December 16, 12 noon ET
Dr. Greenberg is a neurologist and director of the inclusion-body myositis lab participating in research at Harvard University Medical School, Brigham and Women’s Hospital, and Children’s Hospital in Boston. He conducted a small pilot study of the Novartis drug BYM338.
Dr. Tahseen Mozaffar: Understanding autoimmunity
Thursday, January 16, 2:00 pm ET
Dr. Mozaffar is director of the Neuromuscular Center at UC Irvine Medical Center in California and is a nationally recognized expert in his field. He serves as a principal investigator and co-investigator in clinical trials of drugs for neuromuscular conditions, and is the author of many professional journal articles.
Dr. Mark Gourley: Autoantibodies
Tuesday, February 11, 2:00 pm ET
Dr. Gourley is a rheumatologist in Washington, DC, with a long-time connection with the myositis studies at the National Institutes of Health. He has co-authored many studies on the inflammatory myopathies